DATE: December 14, 2020
TIME: 10:00am PST
USP chapter <787>, Subvisible Particulate Matter in Therapeutic Protein Injections, became official August 1, 2014 and provides specific guidance for testing the final dose form of protein-based formulations, such as vaccines. This regulation focuses specifically on protein formulations and, unlike USP<788>, allows the user to test a smaller number of finished product as well as take smaller test aliquots. This paper discusses the challenges that fully implementing USP<787> presents to liquid particle counters with inherently large tare volumes, poor sample-to-sample repeatability with such low sample volumes and inability to precisely deliver small volumes and how the HIAC 9703+ liquid particle counter from Beckman Coulter overcomes these challenges.
Vaccine testing to USP<787>: learn the challenges when using USP<787> for testing vaccines
Learn the difference between USP<788> and USP<787>
Learn why Light Obscuration is the preferred technology for measuring and counting particle contamination in both USP<787> and USP <788>
Learn how the HIAC 9703+ Light Obscuration analyser from Beckman Coulter is designed specifically to help you successfully apply USP<787> to vaccine testing
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.